Literature DB >> 26836930

Persistent Challenges in Pediatric Pulmonary Hypertension.

Rachel K Hopper1, Steven H Abman2, D Dunbar Ivy2.   

Abstract

Pulmonary hypertension and related pulmonary vascular diseases cause significant morbidities and high mortality and present many unique challenges toward improving outcomes in neonates, infants, and children. Differences between pediatric and adult disease are reflected in controversies regarding etiologies, classification, epidemiology, diagnostic evaluations, and therapeutic interventions. This brief review highlights several key topics reflecting recent advances in the field and identifies persistent gaps in our understanding of clinical pediatric pulmonary hypertension.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  pediatric cardiology; pediatric pulmonary; pulmonary hypertension

Mesh：

Year:  2016        PMID： 26836930      PMCID： PMC6026244          DOI： 10.1016/j.chest.2016.01.007

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  72 in total

1.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

3.  STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.

Authors:  Robyn J Barst; Maurice Beghetti; Tomas Pulido; Gary Layton; Irina Konourina; Min Zhang; D Dunbar Ivy
Journal:  Circulation       Date:  2014-03-17       Impact factor: 29.690

4.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

5.  Trends in Hospitalization for Pediatric Pulmonary Hypertension.

Authors:  Bryan G Maxwell; Melanie K Nies; Chinwe C Ajuba-Iwuji; John D Coulson; Lewis H Romer
Journal:  Pediatrics       Date:  2015-07-06       Impact factor: 7.124

6.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

7.  Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension.

Authors:  Shinichi Takatsuki; Erika B Rosenzweig; Warren Zuckerman; Daniela Brady; Michelle Calderbank; D Dunbar Ivy
Journal:  Pediatr Pulmonol       Date:  2012-04-17

8.  Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients.

Authors:  Alban-Elouen Baruteau; Emre Belli; Younes Boudjemline; Daniela Laux; Marilyne Lévy; Gérald Simonneau; Adriano Carotti; Marc Humbert; Damien Bonnet
Journal:  Eur J Cardiothorac Surg       Date:  2014-12-04       Impact factor: 4.191

9.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

10.  B-type natriuretic peptide: prognostic marker in congenital diaphragmatic hernia.

Authors:  Martina A Steurer; Anita J Moon-Grady; Jeff R Fineman; Christine E Sun; Leslie A Lusk; Katherine C Wai; Roberta L Keller
Journal:  Pediatr Res       Date:  2014-09-04       Impact factor: 3.756
View more
  11 in total

1.  Apparent Aortic Stiffness in Children With Pulmonary Arterial Hypertension: Existence of Vascular Interdependency?

Authors:  Michal Schäfer; D Dunbar Ivy; Steven H Abman; Alex J Barker; Lorna P Browne; Brian Fonseca; Vitaly Kheyfets; Kendall S Hunter; Uyen Truong
Journal:  Circ Cardiovasc Imaging       Date:  2017-02       Impact factor: 7.792

2.  Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.

Authors:  M H Bentsen; E Satrell; H Reigstad; S L Johnsen; M Vollsæter; O D Røksund; G Greve; A Berg; T Markestad; T Halvorsen
Journal:  J Perinatol       Date:  2017-06-29       Impact factor: 2.521

3.  Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.

Authors:  Richard M Friesen; Michal Schäfer; D Dunbar Ivy; Steven H Abman; Kurt Stenmark; Lorna P Browne; Alex J Barker; Kendall S Hunter; Uyen Truong
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

4.  Measuring Flow Hemodynamic Indices and Oxygen Consumption in Children with Pulmonary Hypertension: A Comparison of Catheterization and Phase-Contrast MRI.

Authors:  Michal Schäfer; Uyen Truong; Lorna P Browne; Gareth J Morgan; Michael Ross; Richard Ing; Kendall S Hunter; Vitaly O Kheyfets; Steven H Abman; D Dunbar Ivy; Neil Wilson
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

5.  Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population.

Authors:  Lin Li; Susan Jick; Stefanie Breitenstein; Gemzel Hernandez; Alexander Michel; David Vizcaya
Journal:  Pulm Circ       Date:  2017-02-01       Impact factor: 3.017

6.  Differences in pulmonary arterial flow hemodynamics between children and adults with pulmonary arterial hypertension as assessed by 4D-flow CMR studies.

Authors:  Michal Schäfer; D Dunbar Ivy; Steven H Abman; Kurt Stenmark; Lorna P Browne; Alex J Barker; Max B Mitchell; Gareth J Morgan; Neil Wilson; Anar Shah; Madhukar Kollengode; Nivedita Naresh; Brian Fonseca; Michael DiMaria; J Kern Buckner; Kendall S Hunter; Vitaly Kheyfets; Brett E Fenster; Uyen Truong
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-01       Impact factor: 4.733

7.  Explainable machine learning models for predicting 30-day readmission in pediatric pulmonary hypertension: A multicenter, retrospective study.

Authors:  Minjie Duan; Tingting Shu; Binyi Zhao; Tianyu Xiang; Jinkui Wang; Haodong Huang; Yang Zhang; Peilin Xiao; Bei Zhou; Zulong Xie; Xiaozhu Liu
Journal:  Front Cardiovasc Med       Date:  2022-07-26

8.  Risk Factors and Outcomes of Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia: A Meta-Analysis.

Authors:  Ying Chen; Di Zhang; Ying Li; Aixia Yan; Xiaoying Wang; Xiaoming Hu; Hangting Shi; Yue Du; Wenhui Zhang
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

9.  BCAT1 binds the RNA-binding protein ZNF423 to activate autophagy via the IRE1-XBP-1-RIDD axis in hypoxic PASMCs.

Authors:  Wei Xin; Min Zhang; Yang Yu; Songlin Li; Cui Ma; Junting Zhang; Yuan Jiang; Yiying Li; Xiaodong Zheng; Lixin Zhang; Xijuan Zhao; Xuzhong Pei; Daling Zhu
Journal:  Cell Death Dis       Date:  2020-09-16       Impact factor: 8.469

10.  Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension.

Authors:  Weiguang Yang; Alison L Marsden; Michelle T Ogawa; Charlotte Sakarovitch; Keeley K Hall; Marlene Rabinovitch; Jeffrey A Feinstein
Journal:  Pulm Circ       Date:  2018-05-16       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.